key inclusion criteria: * understands and agrees to comply with the study procedures and provides written informed consent. * according to the assessment of the investigator, is in good general health and can comply with study procedures. * body mass index (bmi) of 18 kilograms/square meter (kg/m\^2) to 35 kg/m\^2 (inclusive) at the screening visit (day 0). * for female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, agreement to continue adequate contraception or abstinence through 3 months following the second injection, and not currently breastfeeding. key

key inclusion criteria: * understands and agrees to comply with the study procedures and provides written informed consent. * according to the assessment of the investigator, is in good general health and can comply with study procedures. * body mass index (bmi) of 18 kilograms/square meter (kg/m\^2) to 35 kg/m\^2 (inclusive) at the screening visit (day 0). * for female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, agreement to continue adequate contraception or abstinence through 3 months following the second injection, and not currently breastfeeding. key

key inclusion criteria: - understands and agrees to comply with the study procedures and provides written informed consent. - according to the assessment of the investigator, is in good general health and can comply with study procedures. - body mass index (bmi) of 18 kilograms/square meter (kg/m^2) to 35 kg/m^2 (inclusive) at the screening visit (day 0). - for female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, agreement to continue adequate contraception or abstinence through 3 months following the second injection, and not currently breastfeeding. key

key inclusion criteria: - understands and agrees to comply with the study procedures and provides written informed consent. - according to the assessment of the investigator, is in good general health and can comply with study procedures. - body mass index (bmi) of 18 kilograms/square meter (kg/m^2) to 35 kg/m^2 (inclusive) at the screening visit (day 0). - for female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, agreement to continue adequate contraception or abstinence through 3 months following the second injection, and not currently breastfeeding. key